[
  {
    "V1": "bcr_patient_uuid",
    "V2": "bcr_patient_barcode",
    "V3": "bcr_followup_barcode",
    "V4": "bcr_followup_uuid",
    "V5": "form_completion_date",
    "V6": "radiation_therapy",
    "V7": "person_neoplasm_cancer_status",
    "V8": "vital_status",
    "V9": "days_to_last_followup",
    "V10": "days_to_death",
    "V11": "new_tumor_event_after_initial_treatment",
    "V12": "new_neoplasm_event_type",
    "V13": "new_neoplasm_event_occurrence_anatomic_site",
    "V14": "new_neoplasm_occurrence_anatomic_site_text",
    "V15": "days_to_new_tumor_event_after_initial_treatment",
    "V16": "additional_radiation_therapy",
    "V17": "additional_pharmaceutical_therapy",
    "V18": "metastatic_breast_carcinoma_estrogen_receptor_status",
    "V19": "metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category",
    "V20": "metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type",
    "V21": "metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score",
    "V22": "pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text",
    "V23": "metastatic_breast_carcinoma_estrogen_receptor_detection_method_text",
    "V24": "metastatic_breast_carcinoma_progesterone_receptor_status",
    "V25": "metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category",
    "V26": "metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type",
    "V27": "metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score",
    "V28": "metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text",
    "V29": "metastatic_breast_carcinoma_progesterone_receptor_detection_method_text",
    "V30": "metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status",
    "V31": "metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category",
    "V32": "metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result",
    "V33": "metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text",
    "V34": "metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text",
    "V35": "metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type",
    "V36": "her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number",
    "V37": "metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range",
    "V38": "her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count",
    "V39": "metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value",
    "V40": "metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text",
    "V41": "metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text",
    "V42": "days_to_additional_surgery_metastatic_procedure",
    "V43": "followup_case_report_form_submission_reason",
    "V44": "additional_surgery_locoregional_procedure",
    "V45": "targeted_molecular_therapy"
  },
  {
    "V1": "",
    "V2": "2673794",
    "V3": "",
    "V4": "",
    "V5": "",
    "V6": "2005312",
    "V7": "2759550",
    "V8": "5",
    "V9": "3008273",
    "V10": "3165475",
    "V11": "3121376",
    "V12": "3119721",
    "V13": "3108271",
    "V14": "3128033",
    "V15": "3392464",
    "V16": "3427615",
    "V17": "3427616",
    "V18": "3131865",
    "V19": "3131869",
    "V20": "3203082",
    "V21": "3131873",
    "V22": "3131877",
    "V23": "3131881",
    "V24": "3131884",
    "V25": "3131891",
    "V26": "3203085",
    "V27": "3131988",
    "V28": "3131992",
    "V29": "3131993",
    "V30": "3131997",
    "V31": "3132322",
    "V32": "3132444",
    "V33": "3132448",
    "V34": "3132452",
    "V35": "3132455",
    "V36": "3133734",
    "V37": "3132887",
    "V38": "3132899",
    "V39": "3132903",
    "V40": "3132907",
    "V41": "3132910",
    "V42": "3408682",
    "V43": "3233305",
    "V44": "3008755",
    "V45": "2785850"
  }
]
